AccessMyLibrary provides FREE access to millions of articles from top publications available through your library.
Close
Create a link to this page
Copy and paste this link tag into your Web page or blog:
<a href="http://www.accessmylibrary.com/article-1G1-144695610/phyton-biotech-inc-dfb.html" title="Facts and information about Phyton Biotech Inc, a DFB Pharmaceuticals affiliate, signs licensing agreement with DiAthegen LLC to commercialise growth hormone receptor antagonist that treats acromegaly, cancer, diabetes.">Phyton Biotech Inc, a DFB Pharmaceuticals affiliate, signs licensing agreement with DiAthegen LLC to commercialise growth hormone receptor antagonist that treats acromegaly, cancer, diabetes.</a>
Close
Set up an RSS feed that alerts you when new articles from Chemical Business Newsbase are available.
Frequently asked questions about RSS feeds
Phyton Biotech Inc, a DFB Pharmaceuticals affiliate, signs licensing agreement with DiAthegen LLC to commercialise growth hormone receptor antagonist that treats acromegaly, cancer, diabetes.
(From Chemical Business NewsBase - Press Release)
Phyton Biotech Inc, and DiAthegen LLC have announced the signing of a licensing agreement whereby Phyton will develop and commercialize DiAthegen's long-acting growth hormone receptor antagonist for the treatment of acromegaly, cancer and diabetes. Via this agreement, Phyton receives worldwide marketing rights in exchange for milestone and royalty payments to DiAthegen. Phyton also receives certain …
Related articles from newspapers, magazines, journals, and more
